Stuart Chaussee & Associates, Inc. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stuart Chaussee & Associates, Inc. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2021$19,0002,6750.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders